|Bid||27.90 x 1400|
|Ask||28.49 x 1400|
|Day's Range||27.85 - 28.46|
|52 Week Range||18.10 - 29.73|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||3.86|
|Earnings Date||Feb 26, 2020 - Mar 02, 2020|
|Forward Dividend & Yield||1.75 (6.23%)|
|Ex-Dividend Date||Sep 29, 2020|
|1y Target Est||N/A|
GCI Liberty, Inc. Announces Virtual Investor Meeting
NEW YORK, NY / ACCESSWIRE / October 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:GCI Liberty, Inc.
NEW YORK, NY / ACCESSWIRE / October 16, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:Cellular Biomedicine Group, Inc.